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Research
Epidemiologic investigation supports a  positive 
relationship between exposure to air pollution 
and cardiovascular disease (Rich et al. 2006), 
with the number of deaths from such illness 
estimated to exceed that for respiratory dis-
ease after exposures to elevated levels of pol-
lutants (Dockery 2001). Air pollutants have 
been associated with acute cardiac events, 
including myocardial infarctions and cardiac 
arrests (Forastiere et al. 2005; Rosenthal et al. 
2008; Zanobetti and Schwartz 2005). In addi-
tion, air pollution has been associated with the 
incidence of cardiac arrhythmias (Link and 
Dockery 2010; Peters et al. 2000; Routledge 
and Ayres 2005). Studies have demonstrated 
that discharges by implantable cardioverter 
defibrillators (ICDs) for ventricular arrhyth-
mias increase with higher levels of black car-
bon, fine particles, coarse particles, nitric 
oxide, ozone, nitrogen dioxide, nitric oxide, 
carbon monoxide, and sulfur dioxide (Metzger 
et al. 2007; Peters et al. 2000; Rich et al. 2005, 
2006; Santos et al. 2008). Evidence also sup-
ports an association between measures of air 
pollution and the incidence of supraventricu-
lar arrhythmias. In an ICD study, Rich et al. 
(2005) found a statistically significant relation-
ship between the incidence of supraventricular 
arrhythmias and increased ozone concentra-
tions in the hour preceding the arrhythmia. 
Holter examinations revealed an increased 
risk of supraventricular arrhythmias in asso-
ciation with 5-day moving averages of fine par-
ticles ozone, and sulfate in non smoking adults 
(Sarnat et al. 2006). In yet another Holter 
study, Berger et al. (2006) found that both 
supraventricular and ventricular arrhythmias 
increased in association with PM and nitrogen 
dioxide exposures (in the previous 24–72 hr 
and with 5-day moving averages) among men 
with coronary artery disease. These arrhyth-
mias developed within a few hours of increased 
levels of air pollution (Ljungman et al. 2008).
Although epidemiologic data strongly 
support a relationship between exposure to 
air pollutants and cardiovascular disease, this 
methodology does not permit a description of 
the clinical presentation in an individual case. 
To our knowledge, this is the first case report 
of cardiovascular disease after exposure to ele-
vated concentrations of any air pollutant.
Case Presentation
A 58-year-old Caucasian female visited the 
U.S. Environmental Protection Agency’s 
Human Studies Facility in Chapel Hill, North 
Carolina, to participate in a study requiring 
sequential exposures to filtered air and con-
centrated ambient particles (CAPs). Protocols 
and consent forms were approved by the 
University of North Carolina (UNC) School 
of Medicine Committee on the Protection 
of the Rights of Human Subjects, and the 
subject provided informed consent. Two years 
previously, she had participated in an identical 
exposure protocol without any complication. 
At that time, two 24-hr Holter examinations 
obtained during the exposures to filtered air 
and CAPs demonstrated 29 and 54 episodes 
of supraventricular ectopy, respectively.
On the day of exposure to CAPs, the 
volun teer had no symptoms. The participant 
had a history of osteoarthritis and hypertension, 
and she was being treated with an angiotensin-
converting enzyme inhibitor and a diuretic 
(10 mg lisinopril and 12.5 mg hydrochloro-
thiazide, respectively) for the hypertension. 
Previous surgeries included a hernia repair, a 
cholecystectomy, and a total left knee arthro-
plasty. Her family history was significant due to 
the death of her father at 57 years of age from a 
myocardial infarction. The volunteer was a life-
time non smoker. On physical examination, she 
was 173 cm tall and weighed 104.4 kg (body 
mass index, 34.9; waist, 45 inches). Her pulse 
was regular at 66/min, and her blood pressure 
was 144/61 mmHg. The baseline electrocar-
diogram (ECG) showed normal sinus rhythm 
(Figure 1A). A Holter monitor demonstrated 
evidence of increased supraventricular ectopy, 
with 157 ± 34 premature atrial contractions per 
hour during the 3 hr immediately preceding 
the exposure to CAPs.
Twenty-three minutes into the exposure 
to CAPs (filter weight, 112 μg/m3; particle 
number, 563,912/cc), the telemetry monitor 
revealed that the subject had nonsustained 
atrial fibrillation that quickly organized into 
atrial flutter. She was immediately removed 
from the exposure chamber. The volun-
teer reported no symptoms, and there was 
no change in the physical examination. The 
12-lead ECG verified that she remained in 
atrial flutter (Figure 1B). Her serum electro-
lytes, blood urea nitrogen, creatinine, glucose, 
and complete blood count were all normal. 
Creatine kinase and the MB fraction were 
also normal. During the transfer to the UNC 
Medical Center (~ 2 hr after the onset of the 
arrhythmia), she spontaneously reverted to a 
normal sinus rhythm.
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The patient was admitted to the hospital 
overnight for observation and telemetry. The 
next morning, the ECG documented nor-
mal sinus rhythm. Her serum electrolytes, 
blood urea nitrogen, creatinine, glucose, cre-
atine kinase, and the MB fraction were again 
normal, and her complete blood count was 
normal except for a hematocrit of 35.7% 
(the lower limit of normal is 36.0%). Resting 
trans thoracic echocardiography demonstrated 
normal right ventricular contraction with an 
ejection fraction of 55–60%, aortic sclerosis, 
and diastolic left ventricular dysfunction. The 
left atrium was considered mildly dilated; all 
other chambers of the heart were normal in 
size. She was discharged and was not prescribed 
a new medication. Approximately 6 weeks 
later, she underwent electrophysiology study, 
which did not provoke atrial fibrillation or sig-
nificant atrial ectopy. The study did indicate a 
reentrant circuit of the cavotricuspid isthmus, 
which was ablated to prevent potential future 
episodes of atrial flutter.
Discussion
The volunteer demonstrated evidence of 
increased supraventricular ectopy immediately 
preceding her exposure to CAPs, but there 
was no evidence of atrial arrhythmias. She 
then suffered the onset of atrial fibrillation a 
very short time after being exposed to CAPs. 
Within 2–3 hr after the exposure stopped, 
the arrhythmia resolved and she returned to 
normal sinus rhythm. Atrial fibrillation is the 
most common supraventricular arrhythmia, 
affecting 1–2% of the general population 
(Falk 2001). This arrhythmia is uncommon 
in people < 60 years of age, but it afflicts about 
10% of the population by 80 years of age. Risk 
factors for atrial fibrillation include hyperten-
sion (especially uncontrolled), coronary artery 
disease, heart failure, cerebrovascular disease, 
diabetes, thyroid conditions, sleep apnea, obe-
sity, a past history of rheumatic heart disease 
and congenital heart defects, pericarditis, sick 
sinus syndrome, a family history of atrial fibril-
lation, and echocardiographic abnormalities 
(Kannel and Benjamin 2008, 2009). In addi-
tion, cigarette smoking, alcohol use, caffeine 
consumption, and stimulant drugs can help 
trigger atrial fibrillation. Of these defined risk 
factors, the volunteer had a history of well-
controlled hypertension, and her body mass 
index was consistent with obesity. Her history 
of premature atrial contractions may also have 
increased her risk for atrial fibrillation (Binici 
et al. 2010). In a similar manner, pre existing 
cardiovascular disease, diabetes and impaired 
glucose tolerance, chronic obstructive pulmo-
nary disease, and current cigarette smoking all 
increase susceptibility for cardiovascular disease 
associated with air pollution (Chen et al. 2006; 
Liao et al. 2009; Mills et al. 2007; Wheeler 
et al. 2006; Whitsel et al. 2009; Zareba et al. 
2009). There was no obvious explanation for 
her onset of a supraventricular arrhythmia dur-
ing the exposure. Although coincident atrial 
fibrillation cannot be excluded, the onset of her 
arrhythmia was associated with her exposure to 
ambient air pollution particles. The correlation 
between the resolution of the arrhythmia and 
the termination of the CAP exposure further 
supports a causal relationship between the two.
Systemic inflammation and underlying 
oxidative stress may increase the risk of atrial 
fibrillation (Kumagai et al. 2004). Patients 
with atrial fibrillation demonstrate evidence 
of inflammation, with elevated levels of 
inflammatory markers, including C-reactive 
protein, interleukin-6, and tumor necrosis 
factor-α (Chung et al. 2001; Gaudino et al. 
2003). Some evidence suggests that statin 
treatment may potentially alter the risk for 
this arrhythmia by modifying oxidative stress 
(Siu et al. 2003). The specific association 
between increased arrhythmia induction and 
air pollution may reflect oxidant generation 
and inflammation after exposure, consistent 
with mechanisms involved in the initiation 
and maintenance of some other forms of atrial 
fibrillation (Mazzoli-Rocha et al. 2010). The 
oxidative stress and inflammation associated 
with the pollutant have been postulated to 
affect coronary perfusion and consequently 
enhance the propensity for such arrhythmias 
through tissue ischemia. However, the rapid 
onset of this volunteer’s atrial fibrillation after 
CAP exposure suggests that the basis for the 
arrhythmia may be a disruption of the nor-
mal cardiac autonomic control rather than 
a systemic inflammation, because the lat-
ter would require a longer period of time to 
develop (Routledge and Ayres 2005). In an 
animal model, diesel exhaust increased the sen-
sitivity of the heart to triggered arrhythmias 
via an activation of airway sensory receptors 
[e.g., TRPA1 (transient receptor potential cat-
ion channel A1)] (Hazari et al. 2011). Several 
researchers have suggested that this leads to 
autonomic imbalance and a predisposition for 
arrhythmia development. A comparable mech-
anism has been proposed to explain the cardiac 
response to ozone and cigarette smoke (Joad 
et al. 1998; Mutoh et al. 2000).
CorreCtion
In the manuscript originally published 
online, an author’s name was inadvertently 
omitted. Candice B. Smith had been 
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Figure 1. The volunteer’s ECG (12 lead and rhythm strip) before (A) and immediately after (B) exposure 
to concentrated ambient particles. The ECG before the exposure (A) reveals a regular sinus rhythm with 
defined P waves (arrows); the ECG after the exposure (B) is irregular, with “flutter” waves (arrows).
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